Midway through trading Monday, the Dow traded up 0.54% to 36,146.21 while the NASDAQ rose 1.04% to 15,815.70. The S&P also rose, gaining 0.87% to 4,766.92.
Gainers
Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
Microbot Medical Inc (NASDAQ: MBOT) is soaring Monday morning after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.
Today's 5 Stock Ideas:
JD.Com (JD) - Shares down ~1.20% premarket amid media reports that the Chinese government will establish new regulations for offshore publicly traded companies.
Microbot Medical
Microbot Medical Inc. (NASDAQ:MBOT) announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker's
Microbot Medical Inc. (NASDAQ:MBOT), announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a third patent application covering the Company’s LIBERTY® Robotic
Microbot Medical Inc. (NASDAQ:MBOT) announced that it has and will continue to implement key initiatives that will prepare the LIBERTY® Robotic System for commercialization. In conjunction with recently announced
Microbot Medical Inc. (NASDAQ:MBOT) achieved the design freeze objective for the LIBERTY® Robotic System. This milestone demonstrates the continued progress towards the commercialization of the world's first